Pathstone Family Office’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-307
Closed -$2K 376
2013
Q3
$2K Buy
+307
New +$7.22K 0.01% 288

Other funds holding RNA

Pathstone Family Office's RNA Position: Q4 2013 in Review

Pathstone Family Office sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2013, closing a stake of 307 shares — an estimated $2K sold.

Pathstone Family Office first reported a position in RNA in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 22 funds tracked by Wall St. Rank hold RNA as of Q4 2013.

  • Pathstone Family Office reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2013 after selling out during the quarter.
  • Pathstone Family Office sold 307 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2013, an estimated $2K.
  • Pathstone Family Office first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 1 quarter.
  • Pathstone Family Office's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2013.

Based on Pathstone Family Office's 13F filing for Q4 2013, filed 4 Feb 2014.